i&i Prague successfully mediated an out-licensing of antibodies from the Institute of Molecular Genetics (IMG)
A strategic business collaboration of Institute of Molecular Genetics of the CAS and i&i Prague has been established recently, in October 2017. Despite it is still fresh, this partnership showed its promising potential within first months.
Our very first collaborative effort resulted in out-licensing of one of the IMG assets to an international pharmaceutical company. Institute of Molecular Genetics is one of the top Czech Biotech institutes and the scientists are doing world class research. However, the highest quality of their work has not been fully recognized by companies and investors yet. Since we had a chance to screen full portfolio of IMG projects, we are sure further successful deals with companies and investors should follow quickly. Congratulations and we look for further great deals for IMG!